PRESS RELEASE published on 07/26/2023 at 14:30, 1 year 3 months ago Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 07/25/2023 at 14:30, 1 year 3 months ago Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton"
PRESS RELEASE published on 07/07/2023 at 22:15, 1 year 4 months ago Jaguar Health Reports Approval of All Proposals at 2023 Annual Meeting of Stockholders
PRESS RELEASE published on 06/28/2023 at 14:30, 1 year 4 months ago Napo Pharmaceuticals, a Jaguar Health Company, Submits Investigational New Drug (IND) Application to FDA for Microvillus Inclusion Disease
PRESS RELEASE published on 06/26/2023 at 14:30, 1 year 4 months ago First U.S.-Based Canine Cancer Registry, Founded by Jaguar Health, Joins International Network to Help Advance Canine and Human Cancer Research
PRESS RELEASE published on 06/22/2023 at 14:30, 1 year 5 months ago Jaguar Health Launching AI-Driven Social Media Disease Awareness Education Series Regarding Cancer Therapy-Related Diarrhea in Dogs and People
PRESS RELEASE published on 06/20/2023 at 14:30, 1 year 5 months ago Jaguar Health Subsidiary Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer (MASCC)
PRESS RELEASE published on 06/15/2023 at 14:30, 1 year 5 months ago Jaguar Health to Present June 21st at MedInvest Oncology Investor Conference
PRESS RELEASE published on 06/14/2023 at 14:30, 1 year 5 months ago Ladenburg Thalmann to Host Virtual Discussion June 22nd with Jaguar Health CEO and Leading Patient Advocates on Impact of Cancer Therapy-related Diarrhea on Patients & Importance of the Patient Voice in Supportive Care
PRESS RELEASE published on 06/08/2023 at 21:00, 1 year 5 months ago Canine and Child Cancer Research Advocates Call for Support as Capitol Hill "Goes to the Dogs"
Published on 11/22/2024 at 23:55, 2 days 4 hours ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 2 days 4 hours ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 2 days 4 hours ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 2 days 5 hours ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/24/2024 at 19:16, 8 hours 43 minutes ago EQS-Adhoc: RENK Group AG: Termination of mandate of CEO Susanne Wiegand and appointment of Dr. Alexander Sagel as CEO
Published on 11/24/2024 at 19:07, 8 hours 52 minutes ago EQS-Adhoc: ABO Energy KGaA reduces forecast for the 2024 annual result to EUR 20 to 25 million and confirms market expectation for the 2025 financial year
Published on 11/22/2024 at 18:14, 2 days 9 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 2 days 10 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 06:58, 3 days 21 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 4 days 8 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 4 days 10 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 4 days 10 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
